|
US2006160177A1
|
|
Peptide extended glycosylated polypeptides
|
|
WO2004044190A2
|
|
Zymogen-like protein c polypeptides
|
|
AU2003254641A1
|
|
Interferon beta-like molecules for treatment of cancer
|
|
US2004013644A1
|
|
Interferon beta-like molecules
|
|
WO03106666A2
|
|
Protein c variants with altered properties
|
|
ZA200303964B
|
|
New interferon beta-like molecules.
|
|
BR0308322A
|
|
Use of an interferon beta (ifnb) polypeptide variant, and methods for treating or preventing stroke or stroke and ischemic attack in a primate
|
|
CA2477577A1
|
|
Interferon beta-like molecules for treatment of stroke
|
|
US2004009165A1
|
|
Lysosomal enzymes and lysosomal enzyme activators
|
|
EP1458758A2
|
|
Adiponectin fragments and conjugates
|
|
US2003176328A1
|
|
Adiponectin fragments and conjugates
|
|
WO03055526A2
|
|
Erythropoietin conjugates
|
|
US2003138403A1
|
|
Interferon formulations
|
|
PL367154A1
|
|
New interferon beta-like molecules
|
|
US2003170206A1
|
|
Interferon β variants and conjugates
|
|
ZA200200337B
|
|
New interferon beta-like molecules.
|
|
WO02055532A2
|
|
Variant growth hormone molecules conjugated with macromolecular compounds
|
|
WO0236628A2
|
|
New multimeric interferon beta polypeptides
|
|
WO0236626A1
|
|
Single-chain multimeric polypeptides
|
|
BR0114771A
|
|
Protein c or protein c-like molecules
|
